Posts for BioLineRx Ltd. ($BLRX)

On January 17, 2025, BioLineRx Ltd. filed Form 6-K with the SEC, detailing significant updates and a press release for investors and stakeholders. Compliance with SEC regulations ensured.

Explore BioLineRx Ltd.'s $10 million registered direct offering, aimed at R&D and pipeline expansion. Key details on securities, warrants, and market restrictions included.

BioLineRx Ltd. filed Form 6-K on Jan 6, 2025, detailing a $1.6M capital raise through ADS sales. Key insights on fundraising and regulatory compliance included.